9 Meters Biopharma FY 2020: net loss $61.5M; diluted EPS −$11.60

Key figures from this report

These are the numbers 9 Meters Biopharma reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income−$61.5MAgainst −$27.0M in FY 201910-K income statement, on EDGAR
2. Diluted EPS−$11.60No year-earlier figure tagged. Split-adjusted, as the tables show it; the filing reported −$0.5810-K income statement, on EDGAR
3. Cash and cash equivalents$37.9M+724% from $4.6M in FY 201910-K balance sheet, on EDGAR
4. Cash from operations−$19.4MAgainst −$18.0M in FY 201910-K cash flow statement, on EDGAR